ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds

August 31, 2001

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989